Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous calcium for migraine and osteoporosis
ChiCTR2300067779Phase 4Not yet recruiting
- Sponsor
- PLA 967th Hospital
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in migraine and osteoporosis comparing Intravenous calcium with Normal saline placebo (2 arms). Primary endpoints: Mean change in the average number of headache days, Bone density and 1 more. Planned start May 2023; status: not yet recruiting.
02
Drugs
calcium
03
Conditions
migraineosteoporosis
Beyond the preview
Go deeper on ChiCTR2300067779.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067779.